Compared to the control subjects, the patients in T2DM group and T2DM + AMI group had lower high-density lipoprotein (HDL) levels and higher hypersensitive C-reactive protein (hs-CRP), hemoglobin A1c (HbA1c) and fasting blood glucose levels. The gene discussed is CRP; the disease is type 2 diabetes mellitus.